UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10076) 10076
Book Chapter (53) 53
Dissertation (7) 7
Magazine Article (4) 4
Book / eBook (2) 2
Conference Proceeding (2) 2
Publication (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (8457) 8457
science & technology (6646) 6646
life sciences & biomedicine (6187) 6187
male (6087) 6087
rats (5696) 5696
neurosciences & neurology (4844) 4844
neurosciences (4766) 4766
substantia nigra - drug effects (4710) 4710
substantia nigra (3590) 3590
substantia nigra - metabolism (3170) 3170
parkinson's disease (3004) 3004
dopamine (2847) 2847
dopamine - metabolism (2734) 2734
humans (2163) 2163
rats, sprague-dawley (1895) 1895
female (1890) 1890
corpus striatum - drug effects (1883) 1883
neurons - drug effects (1872) 1872
substantia nigra - physiology (1862) 1862
mice (1741) 1741
substantia nigra - pathology (1594) 1594
corpus striatum - metabolism (1482) 1482
disease models, animal (1427) 1427
neurons (1415) 1415
tyrosine 3-monooxygenase - metabolism (1295) 1295
nervous system (1220) 1220
neurons - metabolism (1189) 1189
dopamine - physiology (1123) 1123
neurology (1123) 1123
rats, inbred strains (1097) 1097
movement disorders (1073) 1073
rats, wistar (1054) 1054
neurodegenerative diseases (1033) 1033
substantia nigra - cytology (1026) 1026
motor activity - drug effects (1001) 1001
mice, inbred c57bl (974) 974
dose-response relationship, drug (908) 908
parkinsons disease (893) 893
pharmacology & pharmacy (892) 892
parkinson’s disease (877) 877
substantia nigra - physiopathology (858) 858
neurons - physiology (856) 856
immunohistochemistry (827) 827
brain (821) 821
striatum (806) 806
behavior, animal - drug effects (794) 794
neurodegeneration (774) 774
time factors (764) 764
clinical neurology (755) 755
biochemistry & molecular biology (745) 745
dopamine receptors (744) 744
oxidopamine (742) 742
apomorphine - pharmacology (706) 706
basal ganglia (705) 705
parkinson disease - metabolism (686) 686
rodents (686) 686
corpus striatum - physiology (651) 651
analysis (645) 645
neostriatum (640) 640
6-hydroxydopamine (634) 634
mptp (608) 608
neuroprotection (604) 604
parkinson disease - pathology (588) 588
neuroprotective agents - pharmacology (583) 583
neurons - pathology (554) 554
brain - metabolism (533) 533
corpus striatum - pathology (525) 525
dopaminergic neurons - drug effects (523) 523
oxidative stress (518) 518
parkinson disease - drug therapy (511) 511
parkinson disease - physiopathology (511) 511
receptors, dopamine - drug effects (504) 504
brain - drug effects (494) 494
dopaminergic neurons - metabolism (467) 467
stereotyped behavior - drug effects (461) 461
cell biology (456) 456
science & technology - other topics (452) 452
multidisciplinary sciences (450) 450
haloperidol - pharmacology (444) 444
in vitro techniques (441) 441
neural pathways - drug effects (438) 438
tyrosine (438) 438
neuroscience (437) 437
research article (432) 432
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (420) 420
tyrosine hydroxylase (420) 420
middle aged (416) 416
rat (410) 410
oxidopamine - toxicity (409) 409
phenols (406) 406
proteins (405) 405
3,4-dihydroxyphenylacetic acid - metabolism (403) 403
aged (397) 397
substantia nigra - enzymology (397) 397
physiological aspects (395) 395
parkinson disease, secondary - chemically induced (388) 388
medicine (384) 384
apoptosis (383) 383
research (382) 382
neurotoxicity (379) 379
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9990) 9990
Russian (79) 79
Japanese (50) 50
Chinese (32) 32
French (30) 30
German (29) 29
Portuguese (10) 10
Polish (9) 9
Spanish (9) 9
Ukrainian (5) 5
Dutch (3) 3
Italian (3) 3
Norwegian (2) 2
Croatian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuron (Cambridge, Mass.), ISSN 0896-6273, 04/2009, Volume 62, Issue 2, pp. 218 - 229
Journal Article
The Journal of neuroscience, ISSN 0270-6474, 01/2018, Volume 38, Issue 5, pp. 1151 - 1159
Substantia nigra pars compacta (SNc) dopamine neurons and their targets are involved in addiction and cue-induced relapse... 
NMDA | Optogenetics | Subthalamic nucleus | AMPA | Dorsal raphé | Pedunculopontine nucleus | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurons, Afferent - drug effects | Receptors, N-Methyl-D-Aspartate - drug effects | Ventral Tegmental Area - drug effects | Dopamine Uptake Inhibitors - pharmacology | Subthalamic Nucleus - drug effects | GABAergic Neurons - drug effects | Neuronal Plasticity - drug effects | Male | Ventral Tegmental Area - cytology | Raphe Nuclei - cytology | Substantia Nigra - cytology | Subthalamic Nucleus - cytology | Cocaine - pharmacology | Substantia Nigra - drug effects | Animals | Raphe Nuclei - drug effects | Dopaminergic Neurons - drug effects | Female | Mice | Mice, Inbred BALB C | Pedunculopontine Tegmental Nucleus - drug effects | Pedunculopontine Tegmental Nucleus - cytology | Receptors, AMPA - drug effects | Ventral tegmentum | Drug abuse | Dopamine | Narcotics | Calcium | Neurons | Glutamic acid receptors (ionotropic) | Substantia nigra | Solitary tract nucleus | N-Methyl-D-aspartic acid receptors | α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors | Pedunculopontine tegmental nucleus | Calcium permeability | Electrical stimuli | Receptors | Mouse devices | α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid | Rodents | Sensory neurons | Cocaine | Receptor mechanisms | Synapses | Index Medicus | pedunculopontine nucleus | dorsal raphé | subthalamic nucleus | optogenetics
Journal Article
Brain structure & function, ISSN 1863-2653, 3/2018, Volume 223, Issue 2, pp. 589 - 595
Journal Article
The Journal of neuroscience, ISSN 1529-2401, 04/2003, Volume 23, Issue 8, pp. 3136 - 3144
.... In the present study, we used electrophysiological and biochemical techniques to investigate the function and the endogenous stimulation of VR1 in dopaminergic neurons of the substantia nigra pars compacta (SNc... 
EPSCs | VR1 | Capsaicin | Presynaptic mechanisms | Substantia nigra | Anandamide | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Synaptic Transmission - physiology | Rats, Wistar | Calcium - metabolism | Capsaicin - pharmacology | Mesencephalon - metabolism | Receptors, Drug - genetics | RNA, Messenger - analysis | Substantia Nigra - metabolism | Excitatory Postsynaptic Potentials - drug effects | Receptors, Drug - agonists | Substantia Nigra - cytology | Dose-Response Relationship, Drug | Excitatory Postsynaptic Potentials - physiology | Polyunsaturated Alkamides | RNA, Messenger - biosynthesis | Synapses - metabolism | Synaptic Transmission - drug effects | Neurons - metabolism | Tetrodotoxin - pharmacology | Neurons - drug effects | Dopamine - metabolism | Endocannabinoids | Diterpenes - pharmacology | Synapses - drug effects | Presynaptic Terminals - drug effects | Rats | Capsaicin - analogs & derivatives | Mesencephalon - chemistry | Calcium Channel Blockers - pharmacology | Arachidonic Acids - pharmacology | Receptors, Drug - metabolism | GABA Antagonists - pharmacology | Patch-Clamp Techniques | Substantia Nigra - drug effects | Animals | Presynaptic Terminals - metabolism | Glutamic Acid - metabolism | In Vitro Techniques | Receptors, Drug - antagonists & inhibitors | Capsaicin receptors | Index Medicus | ARTICLE | substantia nigra | presynaptic mechanisms | capsaicin | anandamide
Journal Article
PloS one, ISSN 1932-6203, 09/2016, Volume 11, Issue 9, pp. e0162460 - e0162460
Background Quantitative susceptibility mapping (QSM) and R2* relaxation rate mapping have demonstrated increased iron deposition in the substantia nigra of patients with idiopathic Parkinson's disease (PD... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Red Nucleus - diagnostic imaging | Thalamus - metabolism | Substantia Nigra - pathology | Humans | Middle Aged | Image Interpretation, Computer-Assisted | Male | Parkinson Disease - drug therapy | Thalamus - pathology | Substantia Nigra - metabolism | Case-Control Studies | Globus Pallidus - diagnostic imaging | Antiparkinson Agents - therapeutic use | Globus Pallidus - metabolism | Female | Parkinson Disease - metabolism | Globus Pallidus - pathology | Severity of Illness Index | Parkinson Disease - pathology | Parkinson Disease - diagnostic imaging | Levodopa - therapeutic use | Thalamus - diagnostic imaging | Brain Mapping - methods | Iron - metabolism | Thalamus - drug effects | Globus Pallidus - drug effects | Magnetic Resonance Imaging | Red Nucleus - metabolism | Substantia Nigra - drug effects | Red Nucleus - drug effects | Substantia Nigra - diagnostic imaging | Aged | Red Nucleus - pathology | Care and treatment | Usage | Diagnostic imaging | Parkinson's disease | Multiple sclerosis | Substantia nigra | Parkinsons disease | Iron | Mapping | Health physics | Substantia grisea | Nuclei | Magnetic susceptibility | Ethics | Maps | Thalamus | Levodopa | Age | Movement disorders | Dopamine receptors | Dopamine | Neurodegenerative diseases | Globus pallidus | Histology | Disease control | Patients | Neurology | Sensitivity | Brain research | Magnetic resonance imaging | Echo surveys | Magnetic permeability | Informed consent | Gene mapping | Index Medicus
Journal Article
The Journal of physiology, ISSN 0022-3751, 05/2011, Volume 589, Issue 10, pp. 2497 - 2514
Non‐technical summary  The loss of dopamine‐containing neurons within the substantia nigra has been implicated in Parkinson's disease... 
Neurosciences | Physiology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Flufenamic Acid - pharmacology | Calcium - metabolism | Receptors, N-Methyl-D-Aspartate - metabolism | Ion Channels - drug effects | Ion Channels - physiology | Substantia Nigra - metabolism | Calcium - physiology | Dopamine - physiology | Egtazic Acid - analogs & derivatives | Neurons - physiology | Transient Receptor Potential Channels - physiology | Neurons - metabolism | Neurons - drug effects | Action Potentials - drug effects | Anti-Inflammatory Agents - pharmacology | Mice, Inbred C57BL | Mice, Transgenic | Chelating Agents - pharmacology | Receptors, N-Methyl-D-Aspartate - physiology | Action Potentials - physiology | Phenanthrenes - pharmacology | Substantia Nigra - drug effects | Animals | Egtazic Acid - pharmacology | Ion Channels - metabolism | Receptors, N-Methyl-D-Aspartate - agonists | Transient Receptor Potential Channels - drug effects | Mice | TRPM Cation Channels - metabolism | Substantia Nigra - physiology | Phenols | Methyl aspartate | Messenger RNA | Parkinson's disease | Neurons | Dopamine | Calcium | Rodents | Parkinsons disease | Index Medicus | Firing pattern | Neurodegenerative diseases | Glutamic acid receptors (ionotropic) | Brain slice preparation | Substantia nigra | Ion currents | N-Methyl-D-aspartic acid receptors | mRNA | transient receptor potential proteins | Neurogenesis | Polymerase chain reaction | Excitotoxicity | Glutamatergic transmission | Receptor mechanisms | Movement disorders | Neuroscience
Journal Article